Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair growth is influenced by interactions between skin layers, growth factors, and hormones, but the exact mechanisms are not fully understood.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Spironolactone can reduce hair growth in women with hirsutism.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Researchers found 71 genetic regions linked to male pattern baldness, which account for 38% of its genetic risk.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Finasteride helps reduce heart issues and improves heart function.

Two enzymes regulate androgen receptor activity, affecting treatments for androgen insufficiency and benign prostatic hyperplasia.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Androgen hormones cause hair follicle scarring in hair loss, and finasteride helps reduce it.

Hormonal male contraception is effective and could be market-ready, but more research is needed to ensure safety for all ethnic groups.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Finasteride, a hair loss drug, may cause long-term sexual side effects due to changes in hormone receptor levels.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Over half of the adult women with acne in the study had higher than normal levels of male hormones, especially DHEA.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.